TKG Advisors LLC Sells 3,728 Shares of Aflac Incorporated (NYSE:AFL)

TKG Advisors LLC lowered its position in Aflac Incorporated (NYSE:AFL) by 15.0% during the third quarter, Holdings Channel reports. The firm owned 21,152 shares of the financial services provider’s stock after selling 3,728 shares during the period. Aflac comprises 1.2% of TKG Advisors LLC’s portfolio, making the stock its 28th largest holding. TKG Advisors LLC’s holdings in Aflac were worth $2,365,000 as of its most recent filing with the SEC.

Several other large investors also recently modified their holdings of AFL. Norden Group LLC acquired a new stake in Aflac in the first quarter valued at approximately $215,000. Mirae Asset Global Investments Co. Ltd. boosted its stake in Aflac by 17.0% during the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 167,204 shares of the financial services provider’s stock valued at $14,356,000 after purchasing an additional 24,284 shares during the last quarter. Tokio Marine Asset Management Co. Ltd. increased its holdings in Aflac by 4.5% during the 1st quarter. Tokio Marine Asset Management Co. Ltd. now owns 12,619 shares of the financial services provider’s stock worth $1,083,000 after purchasing an additional 544 shares in the last quarter. Choreo LLC raised its stake in shares of Aflac by 6.1% in the first quarter. Choreo LLC now owns 2,611 shares of the financial services provider’s stock worth $224,000 after purchasing an additional 150 shares during the last quarter. Finally, Daiwa Securities Group Inc. lifted its holdings in shares of Aflac by 7.5% in the first quarter. Daiwa Securities Group Inc. now owns 53,973 shares of the financial services provider’s stock valued at $4,634,000 after purchasing an additional 3,783 shares in the last quarter. 67.44% of the stock is currently owned by institutional investors and hedge funds.

Aflac Trading Up 0.4 %

Shares of AFL stock traded up $0.44 on Monday, hitting $105.15. 236,323 shares of the company’s stock traded hands, compared to its average volume of 2,227,911. The stock has a market capitalization of $58.89 billion, a price-to-earnings ratio of 15.77, a P/E/G ratio of 2.12 and a beta of 0.96. The company’s fifty day simple moving average is $110.52 and its 200 day simple moving average is $97.93. Aflac Incorporated has a one year low of $75.07 and a one year high of $115.50. The company has a debt-to-equity ratio of 0.32, a quick ratio of 0.10 and a current ratio of 0.08.

Aflac (NYSE:AFL) last announced its quarterly earnings data on Wednesday, October 30th. The financial services provider reported $2.16 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.69 by $0.47. Aflac had a return on equity of 16.34% and a net margin of 22.02%. The firm had revenue of $2.95 billion for the quarter, compared to analysts’ expectations of $4.30 billion. During the same period last year, the firm earned $1.84 earnings per share. The company’s revenue for the quarter was down 40.4% compared to the same quarter last year. Equities analysts forecast that Aflac Incorporated will post 6.87 EPS for the current year.

Aflac Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, December 2nd. Shareholders of record on Wednesday, November 20th will be given a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.90%. The ex-dividend date of this dividend is Wednesday, November 20th. Aflac’s payout ratio is 30.12%.

Analyst Upgrades and Downgrades

Several research firms recently weighed in on AFL. Bank of America boosted their price target on shares of Aflac from $115.00 to $124.00 and gave the stock a “buy” rating in a report on Thursday, October 10th. UBS Group raised their price target on shares of Aflac from $84.00 to $109.00 and gave the stock a “neutral” rating in a research note on Wednesday, August 14th. Citigroup upped their price objective on Aflac from $84.00 to $93.00 and gave the company a “neutral” rating in a research note on Tuesday, July 23rd. Evercore ISI boosted their target price on Aflac from $84.00 to $90.00 and gave the company an “underperform” rating in a research note on Thursday, September 26th. Finally, Morgan Stanley upped their price objective on shares of Aflac from $91.00 to $98.00 and gave the company an “equal weight” rating in a report on Monday, August 19th. Three analysts have rated the stock with a sell rating, ten have issued a hold rating and three have issued a buy rating to the stock. According to MarketBeat, Aflac has an average rating of “Hold” and a consensus target price of $97.87.

Insider Buying and Selling at Aflac

In related news, Director Thomas J. Kenny sold 2,000 shares of Aflac stock in a transaction on Wednesday, August 7th. The shares were sold at an average price of $98.94, for a total value of $197,880.00. Following the sale, the director now owns 18,158 shares in the company, valued at $1,796,552.52. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. 0.90% of the stock is currently owned by corporate insiders.

About Aflac

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.